Results 111 to 120 of about 37,026 (298)

Odanacatib Coating Supports Osseointegration of Implants: A Preclinical Study

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Introduction Odanacatib (ODN), a cathepsin K inhibitor, is a drug that reduces bone resorption while preserving bone formation. ODN was initially developed for the treatment of postmenopausal osteoporosis, but further development as a systemic medication has been discontinued.
Natália dos Santos Sanches   +10 more
wiley   +1 more source

The impact of subcutaneous tissue suturing at caesarean section on wound complications: a meta-analysis. [PDF]

open access: yes, 2017
BACKGROUND: Caesarean wound complications are frequently observed in everyday practice. OBJECTIVES: To study whether subcutaneous tissue closure following caesarean section results in decreased wound complications.
Allaire   +28 more
core   +1 more source

Dual Growth Factor Release From Collagen Based Multilayer Films on Ti‐Surfaces Enhances Periimplant Bone Formation and Angiogenic Activity—An Experimental In‐Vivo Study

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Objectives The aim of the present study was to assess the effect of dual growth factor release from collagen‐based polyelectrolyte multilayer films (PEMs) on titanium implants on periimplant bone formation and angiogenetic activity in minipig mandibles.
Philipp Kauffmann   +7 more
wiley   +1 more source

Dental Implant Osseointegration Following Mandibular Augmentation Using 3D Printed Hydroxyapatite Blocks. An Experimental In Vivo Study

open access: yesClinical Oral Implants Research, EarlyView.
ABSTRACT Objective To evaluate the use and osseointegration of dental implants in combination with 3D‐printed hydroxyapatite (3DHA) blocks featuring gyroid porosity for large mandibular bone augmentation. Methods Mandibular lateral bone augmentation with gyroid‐3DHA blocks was performed bilaterally on four female Göttingen minipigs. After 8 or 12 weeks
Simon Systermans   +5 more
wiley   +1 more source

EFFECT OF INTRA-ABDOMINAL ABSORBABLE SUTURES ON SURGICAL SITE INFECTION

open access: yesNational Journal of Medical Research, 2012
Purpose: To establish whether the rates of surgical site infection (SSI) in gastrointestinal surgery are affected by the type of intra-abdominal suturing: sutureless, absorbable material (polyglactin: Vicryl), and silk.
Harish Chauhan, Upendra Patel
doaj  

Congenital cutaneous fibropapillomatosis in a warmblood foal [PDF]

open access: yes, 2016
In this report, clinical and histological findings of a rare case of a large congenital fibropapilloma on the forehead of a warmblood foal are reported. Surgical excision was curative and no recurrence was observed after nine months.
de Cock, Hilde   +5 more
core   +1 more source

Abdominal decompression for abdominal compartment syndrome in critically ill patients: a retrospective study [PDF]

open access: yes, 2010
Background. The abdominal compartment syndrome (ACS) refers to organ dysfunction that may occur as a result of increased intra-abdominal pressure (IAP). Successful management may require abdominal decompression and temporary abdominal closure (TAC).
Ceelen, Wim   +5 more
core   +1 more source

Comparative analysis of 6-0 nylon and 6-0 vicryl rapide in congenital unilateral cleft lip repair

open access: yes, 2016
Context: The type of suture material used in surgery has been a long standing debate among surgeons. In this study we compared rapidly absorbable suture material (Vicryl Rapide TM or Irradiated Polygalactin 910) with non-absorbable suture material (Nylon
J. D. Dayashankara Rao   +5 more
semanticscholar   +1 more source

Clinical Efficacy of CBCT and 3D‐Printed Replicas in Molar Autotransplantation: A Controlled Clinical Trial

open access: yesDental Traumatology, Volume 41, Issue 2, Page 161-170, April 2025.
ABSTRACT Background/Aim To evaluate the efficacy of the combined cone‐beam (CBCT)/3D‐replicas protocol on the clinical and radiographic outcomes of autotransplanted molars. Material and Methods Controlled clinical trial registered ISRCTN13563091 from August 2019 to September 2022.
Miks Lejnieks   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy